Williams Ettouati, PharmD, received his Doctorât d’ État en Pharmacie from Université René Descartes, Paris V and a Master Arts Biology, University of California, Santa Barbara.
In addition to being Managing Director of this program, he is Director, Industry Relations and Development, and Health Sciences Associate Clinical Professor at the Skaggs School of Pharmacy and Pharmaceutical Sciences.
Dr. Ettouati’s role at the Skaggs School of Pharmacy is to develop and secure strategic collaborations, ranging from drug discovery to corporate sponsored fellowships for PharmD students with pharmaceutical and biotechnology companies.
Prior to this program, Dr. Ettouati developed and has been teaching a graduate course in drug discovery, development and commercialization at UC San Diego. This course was also offered online and had over 60,000 students worldwide.
Before joining the Skaggs School of Pharmacy and Pharmaceutical Sciences, Dr. Ettouati spent twenty years in the pharmaceutical and biotechnology industry.
Dr. Ettouati has proven and extensive experience encompassing multiple functional disciplines in pharmaceutical executive management, in areas such as business development, licensing, marketing and new product planning strategy in biotech and pharmaceutical companies.
Dr. Ettouati served as CEO, President & Co-Founder, Director, GeneProt and Ceptyr early-stage drug discovery biotech companies. In addition, he was Chief Business Officer for several biotech firms such as Hawaii Biotech, responsible for all partnering activities; Vice President Business Development for Syrrx, Aurora/Vertex, Vice President Marketing at DepoTech and product management at Syntex (now Roche), ICI (now Astra-Zeneca). Finally, Dr. Ettouati had an established pharmaceutical consulting practice with many private and public clients.